vs
Side-by-side financial comparison of Aterian, Inc. (ATER) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
Aterian, Inc. is the larger business by last-quarter revenue ($15.1M vs $8.6M, roughly 1.8× Sunshine Biopharma Inc.). Sunshine Biopharma Inc. runs the higher net margin — -25.0% vs -52.5%, a 27.6% gap on every dollar of revenue. On growth, Sunshine Biopharma Inc. posted the faster year-over-year revenue change (-10.6% vs -38.5%). Aterian, Inc. produced more free cash flow last quarter ($-1.0M vs $-1.6M). Over the past eight quarters, Sunshine Biopharma Inc.'s revenue compounded faster (6.6% CAGR vs -13.5%).
Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
ATER vs SBFM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.1M | $8.6M |
| Net Profit | $-7.9M | $-2.1M |
| Gross Margin | 56.1% | 35.3% |
| Operating Margin | -51.1% | -20.9% |
| Net Margin | -52.5% | -25.0% |
| Revenue YoY | -38.5% | -10.6% |
| Net Profit YoY | -512.2% | 0.8% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.1M | $8.6M | ||
| Q3 25 | $19.0M | $9.4M | ||
| Q2 25 | $19.5M | $9.4M | ||
| Q1 25 | $15.4M | $8.9M | ||
| Q4 24 | $24.6M | $9.6M | ||
| Q3 24 | $26.2M | $8.4M | ||
| Q2 24 | $28.0M | $9.3M | ||
| Q1 24 | $20.2M | $7.5M |
| Q4 25 | $-7.9M | $-2.1M | ||
| Q3 25 | $-2.3M | $-883.8K | ||
| Q2 25 | $-4.9M | $-1.8M | ||
| Q1 25 | $-3.9M | $-1.2M | ||
| Q4 24 | $-1.3M | $-2.2M | ||
| Q3 24 | $-1.8M | $-1.2M | ||
| Q2 24 | $-3.6M | $-494.3K | ||
| Q1 24 | $-5.2M | $-1.3M |
| Q4 25 | 56.1% | 35.3% | ||
| Q3 25 | 56.1% | 32.6% | ||
| Q2 25 | 54.3% | 36.4% | ||
| Q1 25 | 61.4% | 30.7% | ||
| Q4 24 | 63.4% | 32.2% | ||
| Q3 24 | 60.3% | 34.0% | ||
| Q2 24 | 60.4% | 25.3% | ||
| Q1 24 | 65.1% | 31.2% |
| Q4 25 | -51.1% | -20.9% | ||
| Q3 25 | -10.7% | -11.5% | ||
| Q2 25 | -23.1% | -21.8% | ||
| Q1 25 | -24.1% | -14.6% | ||
| Q4 24 | -6.5% | -21.7% | ||
| Q3 24 | -6.6% | -13.1% | ||
| Q2 24 | -11.5% | -13.6% | ||
| Q1 24 | -26.1% | -17.9% |
| Q4 25 | -52.5% | -25.0% | ||
| Q3 25 | -12.0% | -9.4% | ||
| Q2 25 | -25.0% | -18.8% | ||
| Q1 25 | -25.4% | -13.3% | ||
| Q4 24 | -5.3% | -22.5% | ||
| Q3 24 | -6.8% | -14.2% | ||
| Q2 24 | -13.0% | -5.3% | ||
| Q1 24 | -25.5% | -17.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.54 | ||
| Q2 25 | — | $-0.82 | ||
| Q1 25 | — | $-0.44 | ||
| Q4 24 | — | $49.77 | ||
| Q3 24 | — | $-11.61 | ||
| Q2 24 | — | $-43.48 | ||
| Q1 24 | — | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.2M | $23.0M |
| Total Assets | $29.6M | $30.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $10.5M | — | ||
| Q1 25 | $14.3M | — | ||
| Q4 24 | $18.0M | — | ||
| Q3 24 | $16.1M | — | ||
| Q2 24 | $20.3M | — | ||
| Q1 24 | $17.5M | — |
| Q4 25 | $15.2M | $23.0M | ||
| Q3 25 | $22.6M | $24.2M | ||
| Q2 25 | $24.3M | $25.7M | ||
| Q1 25 | $27.0M | $22.7M | ||
| Q4 24 | $30.0M | $23.5M | ||
| Q3 24 | $30.6M | $25.0M | ||
| Q2 24 | $30.9M | $23.5M | ||
| Q1 24 | $33.0M | $24.8M |
| Q4 25 | $29.6M | $30.1M | ||
| Q3 25 | $40.1M | $31.5M | ||
| Q2 25 | $45.4M | $32.0M | ||
| Q1 25 | $49.8M | $29.2M | ||
| Q4 24 | $49.5M | $30.6M | ||
| Q3 24 | $52.1M | $30.1M | ||
| Q2 24 | $59.9M | $29.3M | ||
| Q1 24 | $55.7M | $31.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | $-1.6M |
| Free Cash FlowOCF − Capex | $-1.0M | $-1.6M |
| FCF MarginFCF / Revenue | -6.9% | -18.9% |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.0M | $-1.6M | ||
| Q3 25 | $-1.6M | $-727.8K | ||
| Q2 25 | $-4.4M | $-1.3M | ||
| Q1 25 | $-3.9M | $-1.7M | ||
| Q4 24 | $-9.0K | $-3.4M | ||
| Q3 24 | $-722.0K | $-1.4M | ||
| Q2 24 | $2.9M | $-4.6M | ||
| Q1 24 | $-6.0K | $-3.2M |
| Q4 25 | $-1.0M | $-1.6M | ||
| Q3 25 | $-1.6M | $-735.8K | ||
| Q2 25 | $-4.4M | $-1.4M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $-3.5M | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | $2.9M | $-5.6M | ||
| Q1 24 | $-42.0K | $-3.2M |
| Q4 25 | -6.9% | -18.9% | ||
| Q3 25 | -8.4% | -7.8% | ||
| Q2 25 | -22.7% | -15.2% | ||
| Q1 25 | — | -19.3% | ||
| Q4 24 | — | -36.6% | ||
| Q3 24 | — | -22.2% | ||
| Q2 24 | 10.3% | -59.7% | ||
| Q1 24 | -0.2% | -43.1% |
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.2% | 0.1% | ||
| Q2 25 | 0.0% | 1.7% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.0% | 1.1% | ||
| Q3 24 | 0.0% | 6.1% | ||
| Q2 24 | 0.0% | 10.5% | ||
| Q1 24 | 0.2% | 0.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
SBFM
Segment breakdown not available.
